Search
Bone Biologics Corp
BBLGAdd to Watchlist
0.850USD
-0.010-1.17%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.53MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Bone Biologics Corp. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 22.25, with a high of 22.25 and a low of 22.25.
Analyst Rating
Based on
0
analysts
--
Current Rating
12.200
Target Price
+1248.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Bone Biologics Corp's price target?
Analysts forecast that Bone Biologics Corp's price target is USD 22.25, with the highest forecast at USD 22.25 and the lowest forecast at USD 22.25.
How have Bone Biologics CorpBBLG's recent earnings per share performed?
The market expectation was USD -0.43, while Bone Biologics CorpBBLG's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD -0.39.